We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.88%
This Fund
S&P 500
This Quarter
Est. Return
+12.9%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10B
AUM Growth
+$286M
(+2.9%)
Cap. Flow
-$560M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
8.88%
Holding
840
New
58
Increased
311
Reduced
332
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bath & Body Works
BBWI
|
+$26.8M |
| 2 |
PLGO
Pelagos Insurance Capital
PLGO
|
+$25.5M |
| 3 |
ESAB
ESAB
|
+$20.2M |
| 4 |
Hackett Group
HCKT
|
+$17.3M |
| 5 |
AEBI
Aebi Schmidt Holding AG
AEBI
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AL
Air Lease Corp
AL
|
+$64.5M |
| 2 |
Enovis
ENOV
|
+$51.5M |
| 3 |
TGNA
TEGNA Inc
TGNA
|
+$36.1M |
| 4 |
Haemonetics
HAE
|
+$35.3M |
| 5 |
SPNS
Sapiens International
SPNS
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.7% |
| 2 | Technology | 19.16% |
| 3 | Financials | 16.34% |
| 4 | Consumer Discretionary | 13.92% |
| 5 | Healthcare | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Kraft Heinz
KHC
$31.3B
| $5.47M | 0.05% |
210,000
+85,000
| +68% | +$2.31M |
|
452
Carter's
CRI
$1.39B
| $5.45M | 0.05% |
193,272
+167,308
| +644% | +$4.8M |
|
453
Core Laboratories
CLB
$477M
| $5.44M | 0.05% |
440,442
-331,918
| -43% | -$3.89M |
|
454
Halozyme
HALO
$9.88B
| $5.43M | 0.05% |
74,028
-13,001
| -15% | -$864K |
|
455
BrightSpring Health Services
BTSG
$14.3B
| $5.4M | 0.05% |
182,538
+44,505
| +32% | +$1.03M |
|
|
MTSR
456
DELISTED
Metsera Inc
MTSR
| $5.35M | 0.05% |
102,300
-228,980
| -69% | -$8.45M |
|
457
Gogo Inc
GOGO
$559M
| $5.35M | 0.05% |
622,963
-112,985
| -15% | -$1.43M |
|
|
STRZ
458
Starz Entertainment Corp
STRZ
$458M
| $5.34M | 0.05% |
362,645
+60,819
| +20% | +$884K |
|
459
First Financial Bankshares
FFIN
$5B
| $5.3M | 0.05% |
157,561
-100,620
| -39% | -$3.62M |
|
460
Apyx Medical
APYX
$173M
| $5.3M | 0.05% |
2,474,399
+34,696
| +1% | +$73.4K |
|
|
SRTA
461
Strata Critical Medical Inc
SRTA
$440M
| $5.27M | 0.05% |
1,041,243
+683,138
| +191% | +$3.02M |
|
462
Simulations Plus
SLP
$370M
| $5.26M | 0.05% |
348,758
+83,758
| +32% | +$1.22M |
|
463
Flotek Industries
FTK
$847M
| $5.23M | 0.05% |
358,249
+110,192
| +44% | +$1.39M |
|
464
NMI Holdings
NMIH
$3.3B
| $5.15M | 0.05% |
134,284
-1,049
| -0.8% | -$41K |
|
465
CorMedix
CRMD
$588M
| $5.13M | 0.05% |
+441,312
| New | +$5.34M |
|
466
Ares Management
ARES
$28B
| $5.08M | 0.05% |
31,800
| – | – |
|
467
Maravai LifeSciences
MRVI
$996M
| $5.06M | 0.05% |
1,761,764
+484,908
| +38% | +$1.24M |
|
468
Tejon Ranch
TRC
$460M
| $5.01M | 0.05% |
313,818
| – | – |
|
469
Shell
SHEL
$250B
| $5.01M | 0.05% |
70,000
| – | – |
|
470
Sonos
SONO
$1.72B
| $5M | 0.05% |
316,266
+292,500
| +1,231% | +$3.75M |
|
471
Capri Holdings
CPRI
$1.82B
| $4.92M | 0.05% |
246,960
-8,500
| -3% | -$170K |
|
472
Inogen
INGN
$174M
| $4.91M | 0.05% |
600,968
+79,238
| +15% | +$593K |
|
473
Kura Sushi USA
KRUS
$568M
| $4.9M | 0.05% |
82,517
+31,005
| +60% | +$2.47M |
|
474
Energy Recovery
ERII
$435M
| $4.9M | 0.05% |
+317,645
| New | +$4.48M |
|
475
Ryder
R
$9.9B
| $4.87M | 0.05% |
25,790
+14,670
| +132% | +$2.65M |
|
Similar funds
GI
IIM
ACA
VPIM
RI
OIA
HRCM
FPAS
Royce & Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Royce & Associates held 840 positions worth $10B, up 2.9% from $9.74B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Royce & Associates withdrew a net $560M in Q3 2025, closing 78 positions and reducing 332 holdings. Its most notable exit was Sapiens International, an estimated $31.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in Aebi Schmidt Holding AG worth $16.6M.
- Royce & Associates's largest Q3 2025 buy was Aebi Schmidt Holding AG: 1,331,821 shares worth $16.6M.
- Royce & Associates added most to Bath & Body Works in Q3 2025, an estimated $26.8M increase.
- Royce & Associates's biggest Q3 2025 reduction was Air Lease Corp, cutting an estimated $64.5M.
- Royce & Associates fully exited Sapiens International in Q3 2025, selling an estimated $31.5M.
- Royce & Associates's ten largest holdings make up 8.9% of its $10B portfolio in Q3 2025.
- Royce & Associates opened 58 new positions and closed 78 in Q3 2025.
- Royce & Associates's portfolio value rose 2.9% quarter-over-quarter to $10B.
Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.